Universitatsklinikum Essen - Kinder und Jugendmedizin Neuropadiatrie
Welcome,         Profile    Billing    Logout  
 3 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Schara, Ulrike
MOMENTUM, NCT04004065 / 2019-000601-77: Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Efficacy (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment

Checkmark From MOMENTUM trial for DMD
May 2021 - May 2021: From MOMENTUM trial for DMD
Checkmark Interim data from the MOMENTUM study
Dec 2020 - Dec 2020: Interim data from the MOMENTUM study
Checkmark Data from MOMENTUM trial for Duchenne muscular dystrophy
More
Active, not recruiting
2
62
Europe, Canada, US
Vesleteplirsen, SRP-5051
Sarepta Therapeutics, Inc.
Duchenne Muscular Dystrophy
10/23
01/29
NatHis-CNM, NCT03351270: Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies

Completed
N/A
60
Europe
Standardized strength, respiratory and motor function assessments
Institut de Myologie, France, Dynacure
Centronuclear Myopathy
09/21
09/21

Download Options